Abstract
The use of steroids and other pharmaceuticals to gain a competitive edge in athletics has been present in the sports world for a long time. Over the past several years, scientific advances in the detection of sports doping agents and improved collaboration between sports organizations have enhanced the monitoring of fair athletic play. Many have suspected the illegal development of designer steroids by rogue scientists to avoid detection by the standard sports doping drug screen. In 2003, the Olympic Analytical Laboratory at the University of California, Los Angeles discovered the first designer steroid, tetrahydrogestrinone (THG), by using liquid chromatography with tandem mass spectrometry. Over the past year, the THG story continues to shock the sports world with its potential to discredit or terminate several high-profile athletic careers. While confirming the existence of designer steroids is credit to the sports antidoping movement, antidoping agencies will need to continue to invest in research and depend on honest athletic participants to maintain fairness and safety in sports.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References and Recommended Reading
United States Anti-Doping Agency: USADA statement, http://www.usantidoping.org
Catlin DH, Sekera MH, Ahrens BH, et al.: Tetrahydrogestrinone: discovery, synthesis, and detection in urine. Rapid Commun Mass Spectrom 2004, 18:1245–1249. Scientific explanation of the laboratory techniques used to discover THG. Written by the UCLA team responsible for its discovery.
Ritter SK, Washington C, Washington EN: Designer steroid rocks sports world. Chem Eng News 2003, 81:66–69. Review of events that lead to the discovery of THG, as well as an easy to understand explanation of drug screens and laboratory techniques.
Foster ZJ, Housner JA: Anabolic-androgenic steroids and testosterone precursors: erogenic aids and sport. Curr Sports Med Rep 2004, 3:234–241.
Kondro W: Athletes’ "designer steroid" leads to widening scandal. Lancet 2003, 362:1466.
Death AK, McGrath KCY, Kazlauskas R, Handelsman DJ: Tetra-hydrogestrinone is a potent androgen and progestin. J Clin Endocrinol Metab 2004, 89:2498–2500.
United States Anti-Doping Agency: Two U.S. track athletes receive suspensions for positive THG tests, http://www.usan-tidoping.org
Catlin DH, Ahrens BD, Kucherova Y: Detection of norbolethone, an anabolic steroid never marketed, in athletes’ urine. Rapid Commun Mass Spectrom 2002, 16:1273–1275.
Ashley S: Doping by design. Sci Am 2004, 290:22–23.
ACSM News Release. Steroids threaten health of athletes and integrity of sports performance http://www.acsm.org
ESPN.com Associated Press. Anonymous tip leads to seized substance, http://sports.espn.go.com/espn/news/ story?id=1981406
Schnirring L: Experts see silver lining in the THG scandal. Physician Sports Med 2003, 31:16–17.
United States Anti-Doping Agency: U.S. track athlete Jacobs accepts four-year sanction for THG steroid offense. http://www.usantidoping.org
United States Anti-Doping Agency: U.S. track athlete receives suspension for positive THG test, http://www.usantidoping.org
Hilderbrand RL, Wanninger R, Bowers LD: An update on regulatory issues in antidoping programs in sport. Curr Sports Med Rep 2003, 2:226–232.
FDA warning on unapproved performance enhancer. FDA Consum 2004, 38:4.
Handelsman DJ: Designer androgens in sport: when too much is never enough. Sci STKE 2004:pe41.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Malvey, T.C., Armsey, T.D. Tetrahydrogestrinone: The discovery of a designer steroid. Curr Sports Med Rep 4, 227–230 (2005). https://doi.org/10.1007/s11932-005-0041-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11932-005-0041-5